The latest news and breakthrough developments from the field of cancer research. We bring you the latest updates from organisations looking into diagnosing and treating all types of cancers using the latest scientific advancements and what is being done to improve patient care.
In a world first, the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved trofolastat to detect cancerous lesions in men with prostate cancer.
Simon Holt, Honorary Professor at Swansea University, reflects on the key challenges within cancer care and the benefits of genomic testing in improving patient outcomes.
Consuming higher-quality ultra-processed foods (UPFs) might be linked to a higher risk of cancers in the upper aerodigestive tract, encompassing the mouth, throat, and oesophagus.
For fifty years, Western nations have faced a rising wave of lethal esophageal and stomach cancer. AI's predictive capability in these cancers is now evident.
DeepMed has developed an AI oncology diagnostics system, DeepPathTM - LYDIA, to assist histopathologists in performing lymph node metastasis detection quickly and accurately.
Photodynamic therapy, using visible light with lower energy, causes fewer side effects when treating cancer, find Drs. Mary Potasek, Evgueni Parilov, and Karl Beeson, Co-founders of Simphotek, Inc.
Women with early stage breast cancer today are 66% less likely to die within five years of diagnosis than they were in the 1990s, research on the breast cancer survival rate finds.
